Showing results (81-90 of 206) with videos related to

Sort By:
Pageof 21
Rheumatology Advances in Practice|March 17, 2021
COVID-19 and shielding: experiences of UK patients with lupus and related diseasesMelanie Sloan, Caroline Gordon, Elliott Lever, et al.
Journal of Global Antimicrobial Resistance|November 5, 2019
Prediction of trimethoprim/sulfamethoxazole resistance in community-onset urinary tract infectionsMadeline DeMarsh, P Brandon Bookstaver, Caroline Gordon, et al.
Arthritis Care & Research|December 20, 2022
Perceived Stress and Prediction of Worse Disease Activity and Symptoms in a Multiracial, Multiethnic Systemic Lupus Erythematosus CohortSarah Patterson, Laura Trupin, Wendy Hartogensis, et al.
The Lancet. Rheumatology|January 24, 2024
Economic insecurities and patient-reported outcomes in patients with systemic lupus erythematosus in the USA: a cross-sectional analysis of data from the California Lupus Epidemiology StudyDonavon Sandoval-Heglund, Eric Roberts, Joonsuk Park, et al.
Rheumatology (Oxford, England)|January 7, 2022
Will 'the feeling of abandonment' remain? Persisting impacts of the COVID-19 pandemic on rheumatology patients and cliniciansMelanie Sloan, Rupert Harwood, Caroline Gordon, et al.
Rheumatology (Oxford, England)|October 26, 2021
Telemedicine in rheumatology: a mixed methods study exploring acceptability, preferences and experiences among patients and cliniciansMelanie Sloan, Elliott Lever, Rupert Harwood, et al.
Annals of Internal Medicine|October 26, 2021
Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus : A Randomized Controlled TrialMuhammad Shipa, Andrew Embleton-Thirsk, Mariea Parvaz, et al.
The Journal of Rheumatology|June 15, 2023
Medication Cost Concerns and Disparities in Patient-Reported Outcomes Among a Multiethnic Cohort of Patients With Systemic Lupus ErythematosusAlfredo Aguirre, Kimberly DeQuattro, Stephen Shiboski, et al.
The Journal of Rheumatology|February 5, 2005
Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritisKarim Raza, Mike Breese, Peter Nightingale, et al.
Annals of the Rheumatic Diseases|January 15, 2013
Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre studyDaniel J Wallace, Kenneth Kalunian, Michelle A Petri, et al.
Pageof 21